medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2025, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2025; 23 (2)

Skin cancer. A cross-sectional study in a Mennonite population

Chavira-Parada JA, Chavira-Renova JA, Cortés PN, Juárez-Durán ER, Arenas R

Language: Spanish
References: 21
Page: 94-98
PDF size: 240.83 Kb.


ABSTRACT

Background: skin cancer is the most common malignant neoplasm worldwide. Its incidence has increased in recent years. Regarding the Mennonite population, there are no studies in our country on the epidemiology of skin cancer within this community.
Objective: to study the frequency of skin cancer in a Mennonite population.
Materials and methods: a descriptive, observational, retrospective, and cross-sectional study conducted in a private dermatology clinic in Ciudad Cuauhtémoc, Chihuahua. The study involved reviewing medical records of Mennonite patients seen between 2011 and 2015. The following variables were included: age, sex, anatomical location of the dermatosis, type of cancer, and histopathological result.
Results: a total of 1 213 records were reviewed, and 155 cases were included. Of these, 115 presented with a single lesion and 15 had more than one lesion. The most common cancer was basal cell carcinoma (n = 118) at 76.12%, followed by squamous cell carcinoma (n = 32) at 20.64%, and melanoma (n = 5) at 3.22%. The mean age was 59.2 years, ranging from 19 to 92 years.
Conclusion: the Mennonite community in Chihuahua showed a high frequency of skin cancer, with basal cell carcinoma being the most common. This is likely due to the presence of fair phototypes and chronic sun exposure inherent to their sociocultural activities.


REFERENCES

  1. Algarin Y, McCullum C y Patel V, Skin cancer screening practicesamong dermatologists: a survey study, J Drugs Dermatol 2022; 21(11):1235-41. doi: 10.36849/JDD.6660.

  2. Pérez M, Abisaad JA, Rojas KD, Marchetti MA y Jaimes N,Skin cancer: primary, secondary, and tertiary prevention. Parti, J Am Acad Dermatol 2022; 87(2):255-68. doi: 10.1016/j.jaad.2021.12.066.

  3. Rojas KD, Pérez ME, Marchetti MA, Nichols AJ, Penedo FJ yJaimes N, Skin cancer: primary, secondary, and tertiary prevention.Part ii, J Am Acad Dermatol 2022; 87(2):271-88. doi:10.1016/j.jaad.2022.01.053.

  4. Farré X, Blay N, Cortés B, Carreras A, Iraola-Guzmán S y DeCid R, Skin phototype and disease: a comprehensive geneticapproach to pigmentary traits pleiotropy using prs in thegcat cohort, Genes (Basilea) 2023; 14(1):149. doi: 10.3390/genes14010149.

  5. Sitek A, Rosset I, Z˙a¸dzin´ska E, Kasielska-Trojan A, Neskoromna-Je¸drzejczak A y Antoszewski B, Skin color parameters andFitzpatrick phototypes in estimating the risk of skin cancer: acase-control study in the Polish population, J Am Acad Dermatol2016; 74(4):716-23. doi: 10.1016/j.jaad.2015.10.022.

  6. Jiang AJ, Rambhatla PV y Eide MJ, Socioeconomic and lifestylefactors and melanoma: a systematic review, Br J Dermatol2015; 172(4):885-915. doi: 10.1111/bjd.13500.

  7. Taylor Hansen LD, Las migraciones menonitas al norte de Méxicoentre 1922 y 1940, Migraciones Internacionales 2005; 3(1):1-31.

  8. Mortaja M y Demehri S, Skin cancer prevention. Recent advancesand unmet challenges, Cancer Lett 2023; 575:216406. doi:10.1016/j.canlet.2023.216406.

  9. Pérez LL y Bashline B, Skin cancer: prevention, fp Essent 2019;481:28-31.

  10. Jin J, Screening and prevention of skin cancer, jama 2023;329(15):1324. doi: 10.1001/jama.2023.4045.

  11. Yu SY, Hirsch A, Zaslavsky O y Cochrane BB, Risk factors andearly prevention of skin cancer in rural older outdoor workers:a scoping review, Geriatr Nurs 2023; 54:37-45. doi: 10.1016/j.gerinurse.2023.08.017.

  12. Brandt MG y Moore CC, Nonmelanoma skin cancer, FacialPlast Surg Clin North Am 2019; 27(1):1-13. doi: 10.1016/j.fsc.2018.08.001.

  13. Heath MS y Bar A, Basal cell carcinoma, Dermatol Clin 2023;41(1):13-21. doi: 10.1016/j.det.2022.07.005.

  14. Leiter U, Eigentler T y Garbe C, Epidemiology of skin cancer,Adv Exp Med Biol 2014; 810:120-40. doi: 10.1007/978-1-4939-0437-2_7.

  15. Perera E, Gnaneswaran N, Staines C, Win AK y Sinclair R, Incidenceand prevalence of non-melanoma skin cancer in Australia:a systematic review, Australas J Dermatol 2015; 56(4):258-67. doi: 10.1111/ajd.12282.

  16. Wysong A, Squamous-cell carcinoma of the skin, N Engl J Med2023; 388(24):2262-73. doi: 10.1056/NEJMra2206348.

  17. Heppt MV y Leiter U, Cutaneous squamous cell carcinoma: stateof the art, perspectives and unmet needs, J Dtsch DermatolGes 2023; 21(4):421-4. doi: 10.1111/ddg.15052.

  18. Majores M y Bierhoff E, Aktinische Keratose, Morbus Bowen,Keratoakanthom und Plattenepithelkarzinom der Haut [Actinickeratosis, Bowen’s disease, keratoacanthoma and squamouscell carcinoma of the skin], Pathologe 2015; 36(1):16-29. doi:10.1007/s00292-014-2063-3.

  19. Rudningen KE, Hinshaw MA, Aylward JL y Xu YG, Characteristics,evaluation, and outcomes of patients with squamouscell carcinoma lacking histologic continuity to the epidermis,J Am Acad Dermatol 2022; 86(3):662-5. doi: 10.1016/j.jaad.2021.02.039.

  20. Ahmed B, Qadir MI y Ghafoor S, Malignant melanoma: skincancer-diagnosis, prevention, and treatment, Crit Rev EukaryotGene Expr 2020; 30(4):291-7. doi: 10.1615/CritRevEukaryotGeneExpr.2020028454.

  21. Bobos M, Histopathologic classification and prognostic factorsof melanoma: a 2021 update, Ital J Dermatol Venerol 2021;156(3):300-21. doi: 10.23736/S2784-8671.21.06958-3.




2020     |     www.medigraphic.com